Amedisys’ High-Acuity, Non-Medicare Revenue Skyrockets As It Waits For UnitedHealth Group Deal To Close

Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably. The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth […]

What An Amedisys-VitalCaring Deal Would Mean For Each Company

On late Friday, Amedisys Inc. (Nasdaq: AMED) announced that it had agreed to divest certain locations to VitalCaring, in a deal that would be a massive one for the home health industry. It could clear the way for UnitedHealth Group (NYSE: UNH) to finalize its takeover of Amedisys, and also turn VitalCaring into one of […]

Amedisys To Divest Certain Home Health Locations To VitalCaring, Clearing Path For UnitedHealth Group Deal

Amedisys Inc. (Nasdaq: AMED) filed paperwork Friday with the U.S. Securities and Exchange Commission saying it has agreed to divest “certain” locations to an affiliate of home health and hospice company VitalCaring. The divestiture was a way for Amedisys to avoid further antitrust concerns from regulators prior to it joining UnitedHealth Group (NYSE: UNH). UnitedHealth […]

‘Draconian’ And ‘Bewildering’: Inside The 2025 Home Health Proposed Payment Rule

The Centers for Medicare & Medicaid Services’ (CMS) proposed home health payment rule, released Wednesday, included significant cuts for the third straight year. Those cuts, among other proposed changes, raise questions over the stability of the industry in the coming years. It has providers asking themselves and others the question: “Why us?” For an industry […]

What The Amedisys Divestment Snag Means For The Home Health Industry

As UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) work on a divestment strategy that will satisfy regulators, a lot hangs in the balance. For one, UnitedHealth Group and Optum’s deal for the home health and hospice provider Amedisys is one of the largest deals in the industry’s history, only trailing Optum’s deal for Amedisys’ […]

Private Equity-Backed Buyer Drops Out Of Sweepstakes For Divested Amedisys Locations

In early May, it was reported that UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) were working on a divestment package to satisfy regulator concerns over antitrust violations. Capitol Forum had previously reported that Amedisys was aiming to offload more than 100 of its locations to a “private equity-backed buyer.” On Friday, Capitol Forum reported […]

‘Perpetuity Of Uncertainty’: Home Health Providers Await Another Poor Payment Proposal While Left In Limbo On Massive Clawbacks

The Medicaid Access Rule has been finalized, with six years until the implementation of the 80-20 provision. There’s no time to rest for home-based care providers and advocates on the regulation front, however. Summer is near, and that means so is the home health proposed payment rule from the Centers for Medicare & Medicaid Services […]

The Most Game-Changing Home-Based Care Blockbusters Of The Last Decade

Thanks to impactful, large-scale transactions over the last decade, the collective face of home-based care has changed forever. Traditional providers in both home health care and personal home care have merged. Payers became involved in the home-based care space like never before. Of late, retailers have too. But it’s often easy to forget how the […]

CMS To End Hospice MA Carve-In: Insights For Home-Based Care Providers

Grand opening, grand closing. Hospice providers began to work with Medicare Advantage (MA) via the Value-Based Insurance Design (VBID) demonstration in 2021. At the end of 2024, the “hospice carve-in” model will cease. This will have an impact on home health providers who offer hospice services, obviously. But the failure of hospice’s fit within VBID […]